The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of AT101, a novel anti-CD19 CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
 
Dok Hyun Yoon
Honoraria - Amgen; Boryung; Bristol-Myers Squibb; Janssen; Kirin Pharmaceuticals; Roche; Takeda
Consulting or Advisory Role - AbClon; Amgen; Bristol-Myers Squibb; GC Cell; GI Cell; Janssen; Novartis; Pharos iBio; Roche
Research Funding - Boryung; Janssen; Kirin Pharmaceuticals; Roche; Samyang
 
Hyungwoo Cho
No Relationships to Disclose
 
Jae-Cheol Jo
No Relationships to Disclose
 
Seong Hyun Jeong
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose
 
Ki Hyun Kim
Employment - Abclon
Stock and Other Ownership Interests - Abclon (Inst)
 
LeiGuang Cui
Employment - AbClon
 
Tae-bum Lee
Employment - AbClon
 
In-Sik Hwang
Employment - AbClon
 
Young-Ha Lee
Employment - AbClon
 
Yong-Jun Lee
Employment - AbClon
 
Jong-Hoon Kim
Employment - AbClon
 
Marco Ruella
Leadership - viTToria
Consulting or Advisory Role - AbClon; Bayer; Beckman Coulter; BMS Brazil; GlaxoSmithKline; NanoString Technologies
Research Funding - AbClon; Bayer; Beckman Coulter; Bristol-Myers Squibb; GlaxoSmithKline; NanoString Technologies
 
Jong-Seo Lee
Employment - AbClon
 
Junho Chung
No Relationships to Disclose